Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Bupivacaine vs Standard Bupivacaine for Pain Management After Proximal Humerus Fracture Fixation
NCT04928664Phase 4Completed
- Sponsor
- The University of Hong Kong
- Start
- Sep 2020
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of liposomal bupivacaine in shoulder fracture, sponsored by The University of Hong Kong. Started Sep 2020; status: completed.
02
Drugs
liposomal bupivacaine
03
Conditions
shoulder fracture
Beyond the preview
Go deeper on NCT04928664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04928664.